Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies

01 Dec 2010 • by Natalie Aster

'Sales force training is the most important factor for success in generating higher sales revenues. Many companies have realized this and have set up internal training teams for their sales forces'

The report “Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies” by GBI Research provides in-depth analysis of trends, issues and challenges in this industry.

Over the last few years, there has been a paradigm shift in the pharmaceutical industry regarding the methods of effectiveness in selling, which is reflected in the effectiveness of the sales force. Since the industry witnessed a number of sales job cuts, sales forces in the US and Europe have reduced drastically. This reduction has directly influenced pharmaceutical companies to realign the size, structure, and sales strategies of their sales forces. Pharmaceutical companies are now pressurized to generate more profits with lower sales resources. Key account management (KAM) for a pharmaceutical company is about creating a strategic relationship with customers in order to deliver a long term profitable sales growth and achieve a pharmaceutical company’s medium term goal.

Report Details

Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies
Published: October 2010
Price: US$ 3,500.00 US$ 2,975.00 Order the report now and receive a 15% discount!!!
Discount period - Upto 31^th Dec’10

Key features of the report...

• Analysis of the sales force recruitment strategies that impact on the global pharmaceutical industry;
• Analysis of the Cost Pressures for Sales Force Effectiveness in Pharmaceuticals ;
• Analysis of pharmaceutical companies’ competitive landscape including major players such as Pfizer, GlaxoSmithKline, Teva pharmaceuticals, Amgen, Genzyme, Novo nordisk and others.

Key benefits of the report...

• Study of major strategic sales model with case studies that enhances the sales force effectiveness;
• Key sales force training and compensation models that affect the global pharmaceutical industry;
• Key strategies to reduce expenditure on sales force and increase sales force effectiveness.

More information can be found in the report "Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies" by GBI Research.

To order the report or ask for free sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Mrs. Alla Martin
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
www.marketpublishers.com